Ligand validation:5Y5S

CDL: CARDIOLIPIN

CDL is a Ligand Of Interest in 5Y5S designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5Y5S_CDL_M_415	41%	34%	0.128	0.953	1.32	1.27	3	3	1	0	39%	0.39
5Y5S_CDL_H_304	16%	43%	0.306	0.918	1.04	1.15	4	8	2	0	79%	0.79
5Y5S_CDL_Y_103	11%	76%	0.17	0.844	0.47	0.49	-	-	0	0	13%	13
5Y5S_CDL_H_302	11%	38%	0.288	0.87	1.08	1.33	4	9	1	0	64%	0.64
5Y5S_CDL_K_103	10%	44%	0.306	0.837	1	1.17	4	9	3	0	86%	0.86
5Y5S_CDL_S_103	6%	38%	0.228	0.733	1.1	1.31	4	8	8	0	62%	0.62
5Y5S_CDL_Q_104	6%	43%	0.25	0.727	1.09	1.13	4	7	1	0	75%	0.75
5Y5S_CDL_D_103	5%	28%	0.245	0.746	1.45	1.43	4	6	1	0	40%	0.4
5Y5S_CDL_Y_102	3%	30%	0.25	0.693	1.48	1.33	4	4	1	0	40%	0.4
7C52_CDL_M_412	16%	33%	0.212	0.895	1.31	1.34	3	5	2	0	39%	0.39
2GNU_CDL_M_1309	38%	22%	0.122	0.984	1.77	1.5	3	3	0	0	10%	10
3ZDQ_CDL_A_1721	37%	64%	0.215	0.943	0.72	0.65	4	4	0	1	84%	0.42
6JY3_CDL_B_301	33%	24%	0.163	0.908	1.53	1.57	5	14	0	0	64%	0.64
7COH_CDL_A_521	33%	72%	0.212	0.901	0.46	0.6	-	2	6	0	94%	0.94
7A0W_CDL_A_501	32%	37%	0.15	0.908	1.28	1.2	4	6	2	0	52%	0.52

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.